Citations

Mayo Clinic

Clear

88160 citation(s) found for "NA".

Protocol for standardized minimally invasive mouse models of bisphosphonate-related and radiation-induced jaw osteonecrosis
Ding, Zhangfan , Risbud, Makarand V. , Chen, Junyu , Kusumbe, Anjali P , Chen, Junyu , 张家源 , Liu, Hanyu , Chandra, Abhishek

No container title available | July 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.28.735116 | PMID 42427547 Get It

SUMMARY This protocol describes a standardized and reproducible minimally invasive approach for establishing mouse models of bisphosphonate-related osteonecrosis of the jaw (BRONJ) and osteoradionecrosis of the jaw (ORNJ). The method combines a unified low-trauma oral surgical procedure with disease-specific injury induction strategies to generate robust and clinically relevant models of jaw osteonecrosis. For BRONJ, systemic zoledronic acid administration is coupled with mandibular first molar extraction using tape-assisted mouth opening and customized bent micro-forceps, minimizing soft tissue damage and reducing procedural variability. For ORNJ, a customized lead-shielding platform enables precise, noninvasive mandible-targeted irradiation, producing reproducible bone injury while limiting off-target radiation exposure. Together, these complementary models provide a consistent and minimally invasive framework for investigating jaw osteonecrosis arising from distinct etiologies. The protocol supports comprehensive downstream analyses, including micro-computed tomography, histology, and immunofluorescence, and facilitates mechanistic studies of disease pathogenesis, bone regeneration, and therapeutic intervention.
Novel 6,5-Bicyclic Compounds as 5-HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches
Sabnis, Ram W. , Sabnis, Anika R.

ACS Medicinal Chemistry Letters | July 3, 2026 | Volume: 17 | Issue: 8 | Pages: 1705-1706

10.1021/acsmedchemlett.6c00354 | PMID 42621951 Get It

Abstract Provided herein are novel 6,5-bicyclic compounds as 5-HT2A receptor agonists, pharmaceutical compositions, use of such compounds in treating depression, anxiety, substance abuse, and headaches, and processes for preparing such compounds.
Coccidioidal Peritonitis: Clinical Characteristics, Treatment and Outcomes
Shubeilat, Jamilah , Nagarakanti, Sandhya , Almajali, Abeer , Quillen, Jaxon , Buras, Matthew , Speiser, Lisa, Blair, Janis E. , Shubeilat, Jamilah , Nagarakanti, Sandhya Rani , Quillen, Jaxon K , Buras, Matthew R , Blair, Janis E , Speiser, Lisa

Journal of Fungi | July 3, 2026 | Volume: 12 | Issue: 7 | Pages: 489

10.3390/jof12070489 | PMID 42506251 Get It

Peritoneal coccidioidomycosis is a rare, disseminated manifestation of Coccidioides infection with limited representation in the literature. We report 37 proven or probable cases from a single institution, including 12 patients (32%) with immunosuppression. Thirty-six patients received antifungal therapy, all of whom demonstrated clinical response. Among 11 (29.7%) patients who completed and stopped therapy after a median duration of 26 months, 2 (5%) experienced a relapse and were successfully retreated. Nine patients (24%) had no known relapse. Thirteen patients (35%) required modification of antifungal regimens, primarily due to azole adverse effects. Treatment approaches and median duration of therapy (57 months) were similar between immunosuppressed and non-immunosuppressed groups. No deaths were attributable to infection. Overall, outcomes were favorable, with strong clinical responses to azole therapy. Patients without identifiable immunologic deficits or additional sites of dissemination, when managed with antifungal therapy and close clinical, radiologic, and serologic monitoring, may achieve good prognosis, particularly when indefinite azole therapy is not feasible.
Risk of Myeloproliferative Neoplasms in Patients With Inflammatory Bowel Disease and Impact on Outcomes: A Multi‐Centre Matched Analysis
Eldesouki, Mohamed H. , Ibrahim, Ahmed , Marey, Muhammed M., Francis, Fadi, Alsakarneh, Saqr, Ayala, Ernesto, Shaukat, Aasma, Fa, Farraye, Hashash, Jana G., Francis, Fadi F, Eldesouki, Mohamed H. , Ibrahim, Ahmed , Alsakarneh, Saqr , Shaukat, Aasma, Hashash, Jana G.

Alimentary Pharmacology & Therapeutics | July 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/apt.70779 | PMID 42394415 Get It

ABSTRACT Background Inflammatory bowel disease (IBD) and myeloproliferative neoplasms (MPNs) share chronic inflammation and immune dysregulation. Aim We evaluated the incidence of MPNs among patients with IBD and clinical outcomes of IBD–MPN coexistence. Methods Two retrospective cohort analyses were conducted using the TriNetX database. First, adults with ulcerative colitis (UC) or Crohn's disease (CD) were compared with matched non‐IBD controls to estimate incident MPN risk. A coexistence second analysis included patients with UC or CD who developed MPNs and then were matched to IBD without MPN controls to assess 5‐year outcomes, including IBD‐related complications, surgical interventions, colorectal cancer (CRC) and primary sclerosing cholangitis (PSC). Medication subgroup analyses were performed to evaluate associations with MPN risk. Results After matching, 3873 patients with UC–MPN and 3474 patients with CD–MPN were included. Compared with matched non‐IBD controls, incident MPN risk was higher in UC (HR 1.60, p = 0.01) and CD (HR 1.56, p < 0.001). In CD, MPN coexistence was associated with higher risks of CRC (HR 1.52, p = 0.012), intestinal fistula (HR 2.84, p < 0.001), obstruction (HR 2.05, p < 0.001), perforation (HR 2.37, p < 0.001), small bowel resection (HR 3.69, p < 0.001) and colectomy (HR 2.10, p < 0.001). In UC, MPN coexistence was associated with higher risks of CRC (HR 1.50, p = 0.001), PSC (HR 1.75, p = 0.03) and pouchitis (HR 1.68, p = 0.003). Exposure to thiopurines (HR 1.28, p < 0.001) was associated with increased MPN risk, whereas TNF, IL‐23 and JAK inhibitors were not. Conclusions IBD is associated with increased MPN risk, and IBD–MPNs coexistence is associated with worse IBD‐related complications and malignancy risk.
Amyloid exacerbates tau and alpha‐synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model
Rabichow, Benjamin E. , Nixon, Lacey, Tallant, Lauren E., Gibson, Katelin A. , Nascari, David , Barnett, J. Hudson, Massa, Nashali , Fryer, John D., Barnett, J. Hudson , Nascari, David G , Tallant, Lauren , Fryer, John Denis

Alzheimer's & Dementia | July 3, 2026 | Volume: 22 | Issue: 7 | Pages: No page available

10.1002/alz.71639 | PMID 42394391 Get It

Abstract INTRODUCTION Neurodegenerative diseases often involve overlapping alpha‐synuclein (asyn), amyloid beta, and tau proteinopathies, yet the mechanisms, impact, and directionality of their interactions remain unclear. METHODS We induced brain‐wide neuronal asyn/tau pathologies via viral expression of wild‐type asyn, mutant asyn E46K , mutant tau A152T , or both asyn E46K /tau A152T in adult amyloidosis knock‐in mice and controls, either post‐plaque deposition (6 months old) or pre‐plaque (3 months old). Open‐field behavior was assessed baseline and 3 and 6 months post‐transduction, followed by neuropathology and neuroinflammation analyses. RESULTS Post‐plaque induction in amyloid mice increased asyn/tau total and phosphorylated levels and exacerbated amyloid‐related hyperlocomotion/anxiety. Pre‐plaque induction produced robust phosphorylated pathologies irrespective of amyloid, while causing similar amyloid‐dependent behavioral synergy. Tau pathology drove LGALS3 + inflammatory glial responses in white‐matter fibers. DISCUSSION Amyloid context gates vulnerability, with certain synergies manifesting across stages. White‐matter gliosis is a novel mechanism of tau A152T risk. Together, our data argue for the development of stage‐aware, multitarget interventions and biomarkers.
Training the Next Generation of Minimally Invasive HPB Surgeons: Are Current Fellowships Crossing the Learning Curve?
Caldwell, Katharine E. , Sanford, Dominic, Leigh, Natasha, Sanford, Dominic E. , Leigh, Natasha L.

No container title available | July 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-10070818/v1 Get It

Abstract Background Minimally invasive surgery (MIS) improved outcomes in hepatopancreatobiliary (HPB) cases, yet adoption is slowed by technical complexity and steep learning curves. This retrospective review sought to characterize MIS training variations across three fellowship pathways: HPB, complex general surgical oncology (CGSO), and transplant (TXP). Methods We analyzed anonymized Fellowship Council case logs (2014-2023) for 146 HPB, 55 CGSO, and 51 TXP fellows seeking AHPBA certification. Procedures were categorized by platform and type. Results HPB fellows logged significantly more total robotic cases (HPB: 12.5, CGSO: 8.5, TXP: 1.0, p <0.01), including robotic pancreaticoduodenectomies (HPB 4.4, CGSO 3.0, TXP 0.2, p <0.01) and robotic distal pancreatectomies (HPB 3.8, CGSO 3.2, TXP 0.6, p <0.01). Although TXP fellows performed more open major liver resections (HPB 24.0, CGSO 24.7, TXP 35.2, p <0.01), robotic anatomic (HPB 2.1, CGSO 1.5, TXP 0.03, p 0.01) and non-anatomic liver resections (HPB 1.8, CGSO 1.4, TXP 0.2, p <0.01) were highest among HPB fellows. Discussion Meaningful differences in MIS operative exposure exist across training pathways, with TXP fellows trailing significantly in robotic experience. These findings highlight a critical need for standardized MIS curricula to ensure technical proficiency across all HPB surgery pipelines.
Acetazolamide‐Responsive Exertion‐Triggered Episodic Ataxia in DHDDS ‐Related Congenital Disorder of Glycosylation
Muniswamy, Jai Kumar Rajavoor , Selvido, Liam , Zele, Elise Van, Satyanarayana, Raj, Morava, Eva, Muthusamy, Karthik , Van Zele, Elise, Muthusamy, Karthik , Rajavoor Muniswamy, Jai Kumar , Morava, Éva

Movement Disorders Clinical Practice | July 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/mdc3.70723 | PMID 42394283 Get It

The “Stamp‐n‐Tack” Technique: An Ink‐Guided Precision Method for Anchoring Tissue After Releasing Facial Retaining Ligaments in Large Facial Flap Reconstruction
Türk, Cemre Büşra , Vidal, Nahid Y. , Turk, Cemre B

International Journal of Dermatology | July 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/ijd.70561 | PMID 42394118 Get It

Are Children with Disabilities Learning When Included in School? a Capability Approach to Participation in the Learning Process in Afghanistan and Pakistan: A Cluster Control Randomised Trial
Trani, Jean‐Francois , Taff, Steven D., Zhu, Yiqi, Bechara, Saria, Raghavan, Ramesh, Gupta, Isheeta, Babulal, Ganesh M., Taff, Steven D. , Bechara, Saria , Raghavan, Ramesh , Kaplan, Ian, Babulal, Ganesh M. , Bakhshi, Parul , Trani, JF

Journal of Human Development and Capabilities | July 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-25

10.1080/19452829.2026.2691737 Get It

Ethical Considerations in Premortem Heparin Use for Organ Donation after Circulatory Death: A Case Study
Svendsen, Molly, Trost, Lisa , Meltzer, Ellen, Traylor, Blaine, Ellis-Wittenhagen, Jamie , Etzioni, Shiri, Svendsen, Molly , Trost, Lisa, Meltzer, Ellen C. , Traylor, Blaine , Etzioni, Shiri

Journal of Palliative Medicine | July 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/10966218261464666 | PMID 42392992 Get It

Donation after circulatory death (DCD) has become a key avenue for expanding the organ donor pool. Many DCD protocols include premortem intravenous heparin to reduce microthrombus formation and preserve graft viability. This presents the plausible risk of premortem bleeding from an intervention that offers no direct therapeutic benefit to the donor. Ethical concerns and moral distress can arise when potential donors have a catastrophic intracranial hemorrhage with ongoing physiological concern for bleeding risk that is not survivable, but do not currently meet brain death criteria. While prior analyses describe premortem interventions in DCD in conceptual or protocol-driven terms, this case report considers the ethical concerns inherent in premortem heparin administration and illustrates how multidisciplinary teams can operationalize ethical safeguards, including transparent communication, attention to surrogate understanding, and separation of end-of-life decisions from donation-related interventions, to mitigate concerns and minimize moral distress. These issues are directly relevant to palliative care clinicians, who frequently support families during end-of-life crises and when there is consideration for organ donation. Through a multidisciplinary and ethically guided approach, this case illustrates how collaborative decision-making and transparent communication can uphold both donor dignity and transplant integrity.